Remove how-to-patent-in-china
article thumbnail

Offence Or Defence? China’s New Legal “Weapon” Against Intellectual Property Theft Claims and The US’ Response

IPilogue

The US has started a worldwide complaint about China’s new legal strategy against intellectual property (IP) theft claims. Three of these claims were against some of China’s largest telecom companies: Huawei Technologies Co. Beijing said that it would “ strictly enforce patent and copyright laws.” Xiaomi Inc. ,

article thumbnail

New Developments in China Trade Secret Litigation

LexBlog IP

New Developments in China Trade Secret Litigation by Founders Legal China’s Growing Focus on Intellectual Property: The Beijing IP Court Steps Up Protections Trade secrets have become increasingly important in today’s globalized business environment, serving as vital intangible assets for many companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Guest book review: Research Handbook on Intellectual Property and Technology Transfer

The IPKat

His first book “Inside the Patent Factory” was published by Wiley & Sons in 2008, and second book “Harvesting External Innovation” was published by Gower Publishing in 2011. Here is what he has to say about Research Handbook on Intellectual Property and Technology Transfer , edited by Jacob H.

article thumbnail

Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2023-2024

LexBlog IP

The BPCIA also introduced a new scheme to resolve patent disputes involving biosimilar products known as the “patent dance.” ” Since the enactment of the BPCIA, the FDA has approved 46 biosimilar products, and, as the market has grown, litigation activity concerning biosimilars has increased rapidly.

article thumbnail

Light Administrative Injunctions for Designs in China: Status-check on the 2021 Shenzhen AMR Reform

IP Tech Blog

. In June 2021 the Shenzhen Administration for Market Regulation (Shenzhen AMR) issued the first ever provisions on administrative injunctions against the infringement of a design patents, including online infringements. Given the recent implementation, we will need to wait to see if and how such tool will be used. on April 19, 2021.

Designs 62
article thumbnail

Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2020-2021

LexBlog IP

The BPCIA also introduced a new scheme to resolve patent disputes involving biosimilar products known as the “patent dance.” ” Since the enactment of the BPCIA, the FDA has approved nearly 30 biosimilar products, and, as the market has grown, litigation activity concerning biosimilars has increased rapidly.

article thumbnail

Light Administrative Injunctions for Designs in China: Status-check on the 2021 Shenzhen AMR Reform

LexBlog IP

In June 2021 the Shenzhen Administration for Market Regulation (Shenzhen AMR) issued the first ever provisions on administrative injunctions against the infringement of a design patents, including online infringements. Given the recent implementation, we will need to wait to see if and how such tool will be used.

Designs 52